68Ga-PSMA PET in Diagnosing Metastasis in Patients With Ovarian Cancer

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 2, 2018

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Ovarian Carcinoma

Interventions

DRUG

Gallium Ga 68-labeled PSMA-11

Given IV

PROCEDURE

Magnetic Resonance Imaging (MRI)

Given PET/MRI

PROCEDURE

Positron Emission Tomography (PET)

Undergo PET/MRI

Trial Locations (1)

University of California, San Francisco, San Francisco

All Listed Sponsors

collaborator

Radiological Society of North America

OTHER

lead

University of California, San Francisco

OTHER

NCT03857087 - 68Ga-PSMA PET in Diagnosing Metastasis in Patients With Ovarian Cancer | Biotech Hunter | Biotech Hunter